Analysts Set Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Target Price at $11.40
Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the five analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month price […]
23 Oct 08:59 · The Markets Daily